Abstract
The use of novel oral anticoagulation (NOACs) has emerged as an alternative for oral anticoagulation with vitamin-K antagonists in different clinical settings. However, despite the several advantages of these new drugs, there are also several limitations and cautious is recommended in different clinical settings in patients with a high comorbidity index. This review article will describe the current evidence of treatment monitoring, possible drug interaction, and will give an overview about treatment options in case of complications.
Keywords: Coumadin, novel oral anticoagulation, thrombembolism, warfarin.
Cardiovascular & Hematological Disorders-Drug Targets
Title:Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications
Volume: 15 Issue: 2
Author(s): Aydin Huseynov, Stefan Baumann, Ibrahim El-Battrawy and Ibrahim Akin
Affiliation:
Keywords: Coumadin, novel oral anticoagulation, thrombembolism, warfarin.
Abstract: The use of novel oral anticoagulation (NOACs) has emerged as an alternative for oral anticoagulation with vitamin-K antagonists in different clinical settings. However, despite the several advantages of these new drugs, there are also several limitations and cautious is recommended in different clinical settings in patients with a high comorbidity index. This review article will describe the current evidence of treatment monitoring, possible drug interaction, and will give an overview about treatment options in case of complications.
Export Options
About this article
Cite this article as:
Huseynov Aydin, Baumann Stefan, El-Battrawy Ibrahim and Akin Ibrahim, Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications, Cardiovascular & Hematological Disorders-Drug Targets 2015; 15 (2) . https://dx.doi.org/10.2174/1871529X1502151209112437
DOI https://dx.doi.org/10.2174/1871529X1502151209112437 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The AKT Axis as a Therapeutic Target in Autoimmune Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Liraglutide Therapy in a Prediabetic State: Rethinking the Evidence
Current Diabetes Reviews Angiotensin Converting Enzyme (ACE) Inhibitory Peptides: Production and Implementation of Functional Food
Current Pharmaceutical Design Whole Milk and Full-Fat Dairy Products and Hypertensive Risks
Current Hypertension Reviews Thrombolysis in Ischemic Stroke: Focus on New Treatment Strategies
Recent Patents on Cardiovascular Drug Discovery Therapeutic Use of Calcitriol
Current Vascular Pharmacology Home Blood Pressure-guided Anticipation Management of Hypertension: Effective to the Gap Between the Guidelines and the Individualized Medicine
Current Hypertension Reviews Dysregulated NF-κB Pathway in Peripheral Mononuclear Cells of Alzheimers Disease Patients
Current Alzheimer Research Pharmacokinetics and Acute Toxicity of a Histone Deacetylase Inhibitor, Scriptaid, and its Neuroprotective Effects in Mice After Intracranial Hemorrhage
CNS & Neurological Disorders - Drug Targets Harvesting New Therapeutic Avenues with Stem Cell Applications
Current Neurovascular Research Pathological Features of Antibody-Mediated Rejection
Current Drug Targets - Cardiovascular & Hematological Disorders Aeruginosin Analogs and Other Compounds with Rigid Bicyclic Structure as Potential Antithrombotic Agents
Cardiovascular & Hematological Agents in Medicinal Chemistry Why Image the Pancreatic Beta Cell?
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention
Current Drug Targets 3D Cell and Scaffold Patterning Strategies in Tissue Engineering
Recent Patents on Biomedical Engineering (Discontinued) Interaction of Different Proteins with GABA<sub>A</sub> Receptor and their Modulatory Effect on Inhibitory Neural Transmission Leads to Epilepsy
CNS & Neurological Disorders - Drug Targets Role of the Growth Suppressor p27Kip1 During Vascular Remodeling
Current Vascular Pharmacology Review on Bosentan, A Dual Endothelin Receptor Antagonist for the Treatment of Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice
Current Vascular Pharmacology Impact of Active Antihyperglycemic Components as Herbal Therapy for Preventive Health Care Management of Diabetes
Current Molecular Medicine